News
There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...
The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...
SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...
The FDA launched Elsa, its first generative AI tool, to streamline reviews and modernize agency workflow across all centers.
Hyperfine (Nasdaq:HYPR) announced today that the FDA cleared its latest portable MRI scanner powered by proprietary AI ...
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results